Funder: National Institutes of Health
Due Dates: August 15, 2025 (AIDS Application Due Date)
Funding Amounts: Up to $1,500,000 direct costs (total for 4 years; $375,000/year); all funds disbursed in year 1; plus applicable F&A costs.
Summary: Supports early stage investigators proposing innovative research at the intersection of substance use disorders and HIV/AIDS, aiming to reduce HIV incidence and improve outcomes for substance-using populations.
Key Information: Applicants must be Early Stage Investigators (ESI) within 10 years of terminal degree or medical residency; only one PD/PI per application; limited submission.